| 000 | 01397 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514065124.0 | ||
| 264 | 0 | _c20030529 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a1474-175X | ||
| 024 | 7 |
_a10.1038/nrc1074 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLongley, Daniel B | |
| 245 | 0 | 0 |
_a5-fluorouracil: mechanisms of action and clinical strategies. _h[electronic resource] |
| 260 |
_bNature reviews. Cancer _cMay 2003 |
||
| 300 |
_a330-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aDihydrouracil Dehydrogenase (NADP) |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xpharmacology |
| 650 | 0 | 4 | _aMicrosatellite Repeats |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 |
_aOxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA _xmetabolism |
| 650 | 0 | 4 |
_aThymidine Phosphorylase _xgenetics |
| 650 | 0 | 4 |
_aThymidylate Synthase _xgenetics |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xphysiology |
| 700 | 1 | _aHarkin, D Paul | |
| 700 | 1 | _aJohnston, Patrick G | |
| 773 | 0 |
_tNature reviews. Cancer _gvol. 3 _gno. 5 _gp. 330-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrc1074 _zAvailable from publisher's website |
| 999 |
_c12514775 _d12514775 |
||